(Q43272514)
Statements
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial (English)
Glen Clack
Richard D Finkelman
Rosemary A Hannon
Martin Rimmer
Alan Swaisland
J Andrew Lockton